Drugs / N-acetyl-aspartyl-glutamic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01203540 | Oct 2010 → Jan 2011 | conjunctivitis | Laboratoires Thea | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-acetyl-aspartyl-glutamic acid | “comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device.” NCT01203540 ↗ |
| Known as | NAAGA | “comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device.” NCT01203540 ↗ |